Sharmiashvili NI, Santaolaya CM

Language: Spanish
References: 13
Page: 163-168
PDF size: 188.77 Kb.

ABSTRACT

Introduction: Only 10-20% of patients with liver tumors are candidates for surgical resection. Radiofrequency ablation is a localized thermal treatment causing the tumor cell destruction with the temperature exceeding 50 °C. Objective: To evaluate the efficacy of the radiofrecuency treatment and its complications in primary and secondary hepatic tumors studied in a prospective way at the Hospital Universitario de La Princesa, Madrid. Material and methods: We studied 34 patients not eligible for surgical treatment. We set the following variables: clinical characteristics, blood analysis, radiological Imaging, lesion type, the technique used, hospital stay, complications and the results on a long run. Results: Out of 34 patients 23 were male and 11 female with mean age of 71 years. 3 patients were dismissed because of the tumor size and its proximity to the vascular structures. In total 31 patients underwent the radiofrequency. Technique used: laparotomy in 14 patients and percutaneous 17. Most frequent local complication was liver abscess (19.4%). The mean hospital stay was longer in laparotomy patients: 22 days (minimum 10 and maximum 34 days) and 3 days in case of percutaneous technique (minimum 2 and maximum 4 days). Conclusion: Radiofrequency ablation for liver lesions is a safe technique for the patients with primary and secondary none surgically removable liver tumors. The percutaneous method is associated with fewer complications, shorter hospital stay and better life quality at a short run.

REFERENCES

1. Llovet JM, Beaugrand M. Hepatocellular carcinoma: present status and future prospects. J Hepatol. 2003; 38: S136-S149.

2. Callejo Velasco D, Guerra RM, Blasco AJA. Revisión sistemática y análisis costo-efectividad de la ablación por radiofrecuencia en tumores y metástasis hepáticas. Madrid: Plan de Calidad para el SNS del MSPS. Unidad de Evaluación de Tecnologías Sanitarias, Agencia Laín Entralgo, 2009. Informes de Evaluación de Tecnologías Sanitarias: UETS 2007/8.

3. Fuster-Obreón J, Charco-Torra R, García-Valdecasas SJC. Tumores primarios del hígado. En: Parrilla Parido P, Jaurrieta ME, Moreno Azcoitia M, eds. Cirugía AEC. Manual de la Asociación Española de Cirujanos. Madrid: Médica Panamericana; 2005: 490-4.

4. Bruix J, Llovet JM. Prognostic prediction and treatment strategy in hepatocellular carcinoma. Hepatology. 2002; 35: 519-24.

5. Romeo R, Colombo M. The natural history of hepatocellular carcinoma. Toxicology. 2002; 181-182: 39-42.

6. Cabassa P, Donato F, Simeone F, Grazioli L, Romanini L. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol. 2006; 186: S316-2l.

7. Marín-Hargreaves G, Azoulay D, Bismuth H. Hepatocellular carcinoma: surgical indications and results. Crit Rev Oncol Hemat. 2003; 47: 13-27.

8. Hinshaw JL, Laeseke PF, Winter TC 3rd, Kliewer MA, Fine JP, Lee FT Jr. Radiofrequency ablation of peripheral liver tumors: intraperitoneal 5% dextrose in water decreases postprocedural pain. AJR Am J Roentgenol. 2006; 186: S306-10.

9. Aloia TA, Vauthey JN, Loyer EM, Ribero D, Pawlik TM, Wei SH et al. Solitary colorectal liver metastasis: resection determines outcome. Arch Surg. 2006; 141: 460-7.

10. Iannitti DA, Dupuy DE, Mayo-Smith WW, Murphy B. Hepatic radiofrequency ablation. Arch Surg. 2002; 137: 422-427.

11. Parikh AA, Curley SA, Fomage BD, Ellis LM. Radiofrequency ablation of hepatic metastases. Semin Oncol. 2002; 29: 168-82.

12. Garcea G, Lloyd TD, Aylott C, Maddern G, Berry DP. The emergent role of focal liver ablation techniques in the treatment of primary and secondary liver tumours. Eur J Cancer. 2003; 39: 2150-64.

13. Berber E, Flesher N, Siperstein AE. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg. 2002; 26: 985-90.